News
The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side ...
This one-time weight-loss drug leader has suffered several setbacks lately. It isn't wise to count out this veteran ...
The European Medicines Agency's (EMA) safety committee has concluded that a potentially dangerous eye condition is a very ...
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...
Novo Nordisk has filed a lawsuit in Delhi High Court. The suit aims to stop Dr Reddy's Laboratories and OneSource from ...
Many Americans struggle with being overweight, social stigmas still prevent people from talking to doctors and seeking ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
US woman Caroline Davis shared incredible before and after images of her weight loss after using semaglutide drug Wegovy.
Rising teen obesity prompts a surge in Novo Nordisk's Wegovy usage among adolescents, with prescriptions climbing 50% in 2024 ...
An Ozempic warning has been issued by the Medicines and Healthcare products Regulatory Agency (MHRA) for any women taking ...
Almost exactly a year after launching its Obesity Association, the American Diabetes Association (ADA) has recruited Novo ...
Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results